Item 5.02 Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers
On January 16, 2021, Marizyme, Inc. ("Marizyme") appointed Roger Schaller as
Executive Vice President of Commercial Operations. Mr. Schaller will be
compensated as follows: $250,000 per annum and 40,000 options for common stock
of Marizyme.
On January 1, 2021, Bruce Harmon, CFO of Marizyme, had a modification in salary
and will receive $250,000 per annum.
Roger Schaller, Executive Vice President, Commercial Operations.
Roger Schaller is the Executive Vice President of Commercial Operations for
Marizyme. Mr. Schaller has over 30 years of life science industry experience in
commercial operations, business development and, new product development for
large and entrepreneurial companies. His experience has been with Medical, Life
Sciences, Electronics and Bio Tech products with Global responsibilities and
executive leadership. Most recently, Roger Schaller was Vice President of
Business Development at Promex Industries, a Silicon Valley Company specializing
in Biotech and Medical Device Microelectronics serving the diagnostic, medical
device and genomic industries. Prior to joining Promex, he served as Chief
Operating Officer (COO) for Integrated Nano-Technologies, producing DNA point of
care testing systems and, before that, as COO and Vice President of Business
Development for U.S. operations, for Coyote Biosciences, developing Life Science
and Diagnostic products. He previously held a succession of executive posts with
biotech and medical diagnostic firms including Affymetrix/Thermo Fisher,
RainDance Technologies and as Senior Director of Marketing, Sales and Business
Development at Cepheid, he was instrumental in establishing the initial Sales
and Marketing Team and market entry that lead to the success of Cepheid, which
is now a Danaher Company. Mr. Schaller holds Bachelor of Science degrees in
Medical Technology and Biology from Illinois State University with a minor in
Chemistry.
© Edgar Online, source Glimpses
MARIZYME, INC. 
